Association between TNF-α polymorphisms and cervical cancer risk: A meta-analysis

Molecular Biology Reports

Volumn 39, Issue 3, 2012, Pages 2683-2688

  Liu, Li ^a,b,c   Yang, Xi ^b   Chen, Xiaojun ^a   Kan, Tinjing ^c   Shen, Yan ^c   Chen, Zengyan ^a   Hu, Zhibin ^b,c  

^a Tumor Hospital of Nantong City   (China)

^b Prevention and Treatment   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Cervical cancer; Meta analysis; Polymorphism; TNF

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ASIAN; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CAUCASIAN; ETHNIC DIFFERENCE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HUMAN; NEGRO; TNFA GENE; UTERINE CERVIX CANCER;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA; UTERINE CERVICAL NEOPLASMS;

EID: 84863842065     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-1022-9     Document Type: Article

References (34)

1. Parkin DM, Bray F, Ferlay J et al (2005) Global cancer statistics, 2002. CA Cancer J Clin 55(2):74-108
2. Muñoz N, Bosch FX, de Sanjosé S et al (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348(6):518-527
3. Chen X, Han S, Wang S et al (2009) Interactions of IL-12A and IL-12B Polymorphisms on the susceptibility of cervical cancer in Chinese women. Clin Cancer Res 15(1):400-405
4. Santos AM, Sousa H, Catarino R et al (2005) TP53 codon 72 polymorphism and risk for cervical cancer in Portugal. Cancer Genet Cytogenet 159(2):143-147
5. Ho GY, Bierman R, Beardsley L et al (1998) Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338(7):423-428
6. Strieter RM, Kunkel SL, Bone RC (1993) Role of tumor necrosis factor-alpha in disease states, inflammation. Crit Care Med 21(10 Suppl):S447-S463
7. Ardizzoia A, Lissoni P, Brivio F et al (1992) Tumor necrosis factor in solid tumors: increased blood levels in the metastatic disease. J Biol Regul Homeost Agents 6(3):103-107
8. Wilson AG, Symons JA, McDowell TL et al (1997) Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 94(7): 3195-3199
9. Fong CL, Siddiqui AH, Mark DF (1994) Identification and characterization of a novel repressor site in the human tumor necrosis factor ogene. Nucl Acids Res 22(6):1108-1114
10. Singh H, Jain M, Sachan R et al (2009) Association of TNFA (-308G[A) and IL-10 (-819C[T) promoter polymorphisms with risk of cervical. Int J Gynecol Cancer 19(7):1190-1194
11. Wang SS, Bratti MC, Rodríguez AC (2009) Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancer. J Infect Dis 199(1):20-30
12. Duarte I, Santos A, Sousa H et al (2005) G-308A TNF-alpha polymorphism is associated with an increased risk of invasive cervical cancer. Biochem Biophys Res Commun 334(2):588-592
13. Calhoun ES, McGovern RM, Janney CA et al (2002) Host genetic polymorphism analysis in cervical cancer. Clin Chem 48(8): 1218-1224
14. Ivansson EL, Juko-Pecirep I, Gyllensten UB (2010) Interaction of immunological genes on chromosome 2q33 and IFNG in susceptibility to cervical cancer. Gynecol Oncol 116(3):544-548
15. Stanczuk GA, Sibanda EN, Tswana SA et al (2003) Polymorphism at the -308-promoter position of the tumor necrosis factoralpha (TNF-alpha) gene, cervical cancer. Int J Gynecol Cancer 13(2):148-153
16. Gostout BS, Poland GA, Calhoun ES et al (2003) TAP1, TAP2, HLA-DR2 alleles are predictors of cervical cancer risk. Gynecol Oncol 88(3):326-332
17. Jang WH, Yang YI, Yea SS et al (2001) The -238 tumor necrosis factor-alpha promoter polymorphism is associated with decreased susceptibility to cancers. Cancer Lett 166(1):41-46
18. Govan VA, Constant D, Hoffman M et al (2006) The allelic distribution of -308 tumor necrosis factor-alpha gene polymorphism in South African women with cervical cancer and control women. BMC Cancer 6:24
19. Deshpande A, Nolan JP, White PS et al (2005) TNF-alpha promoter polymorphisms and susceptibility to human papillomavirus 16-associated cervical cancer. J Infect Dis 191(6):969-976
20. Kohaar I, Thakur N, Salhan S et al (2007) TNFalpha-308G/A polymorphism as a risk factor for HPV associated cervical cancer in Indian population. Cell Oncol 29(3):249-256
21. Zintzaras E, Ioannidis JP (2005) Heterogeneity testing in metaanalysis of genome searches. Genet Epidemiol 28(2):123-137
22. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539-1558
23. Egger M, Davey Smith G, Schneider M et al (1997) Bias in metaanalysis detected by a simple, graphical test. BMJ 315(7109): 629-634
24. Dinarello CA, Wolff SM (1993) The role of interleukin-1 in disease. N Engl J Med 328(2):106-113
25. Tracey KJ, Cerami A (1993) Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol 9:317-343
26. Carswell EA, Old LJ, Kassel RL et al (1975) An endotoxininduced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72(9):3666-3670
27. Leibovich SJ, Polverini PJ, Shepard HM et al (1987) Macrophage- induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature 329(6140):630-632
28. Woodworth CD, McMullin E, Iglesias M et al (1995) Interleukin 1 alpha and tumour necrosis factor alpha stimulate autocrine amphiregulin expression and proliferation of human Papillomavirus-immortalized and carcinoma-derived cervical epithelial cells. Proc Natl Acad Sci USA 92(7):2840-2844
29. Bequet-Romero M, López-Ocejo O (2000) Angiogenesis modulators expression in culture cell lines positives for HPV-16 oncoproteins. Biochem Biophys Res Commun 277(1):55-61
30. Tjiong MY, van der Vange N, ter Schegget JS et al (2001) Cytokines in cervicovaginal washing fluid from patients with cervical neoplasia. Cytokine 14(6):357-360
31. Hajeer AH, Hutchinson IV (2001) Influence of TNF alpha gene polymorphisms on TNF alpha production and disease. Hum Immunol 62(11):1191-1199
32. Kroeger KM, Carville KS, Abraham LJ (1997) The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 34(5):391-399
33. Kaluza W, Reuss E, Grossmann S et al (2000) Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-alpha 238A promoter polymorphism. J Invest Dermatol 114:1180-1183
34. Li N, Franceschi S, Howell-Jones R et al (2011) Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer 128(4):927-935. doi:10.1002/ijc.25396